Publications

development

2022

Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates

PLOS

MMGH Author(s)

To play, press and hold the enter key. To stop, release the enter key.

policy

2022

WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants – Key considerations for global use

Vaccine

MMGH Author(s)

To play, press and hold the enter key. To stop, release the enter key.

development

2021

A Financial and Global Demand Analysis to Inform Decisions for Funding and Clinical Development of Group B Streptococcus Vaccines for Pregnant Women

Clinical Infectious Diseases 74, Suppl.1, 2022: S70–S79

MMGH Author(s)

To play, press and hold the enter key. To stop, release the enter key.

strategy

2022

Application of the Child Health and Nutrition Research Initiative (CHNRI) methodology to prioritize research to enable the implementation of Ending Cholera: A global roadmap to 2030

PLOS

MMGH Author(s)

To play, press and hold the enter key. To stop, release the enter key.

evaluation

2021

An External Evaluation on the INCLEN Research Program to Emphasize the Public Health Significance of Childhood Pneumonia in India

Indian Pediatrics Volume 58

MMGH Author(s)

To play, press and hold the enter key. To stop, release the enter key.

strategy

2021

The World of Immunization: Achievements, Challenges, and Strategic Vision for the Next Decade

The Journal of Infectious Diseases, Volume 224, Issue Supplement 4, pp. S452-S467

MMGH Author(s)

To play, press and hold the enter key. To stop, release the enter key.

evaluation

2022

Covid-19 vaccines: the factors that enabled unprecedented timelines for clinical development and regulatory authorisation

Wellcome Trust

MMGH Author(s)

To play, press and hold the enter key. To stop, release the enter key.

development

2021

Stakeholder Perceptions About Group B Streptococcus Disease and Potential for Maternal Vaccination in Low- and Middle-Income Countries

Clinical Infectious Diseases 74, Suppl.1, 2022: S80–S87

MMGH Author(s)

To play, press and hold the enter key. To stop, release the enter key.

evaluation

2021

Human leishmaniasis vaccines: Use cases, target population and potential global demand

PLOS

MMGH Author(s)

To play, press and hold the enter key. To stop, release the enter key.